Clinical trial
Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a…
NCT00310648 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00310648 |
|---|---|
| Title | Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years) |
| Official title | Part 1:Phase I Open-Label, Single-Center to Evaluate the Safety of a Commercially Available Adjuvanted Influenza Vaccine When Administered to Elderly Subjects Part 2: A Phase III, Randomized, Controlled, Observer-Blind, Single-Center Study to Evaluate the Immunogenicity and Safety of a Commercially… |
| Lead sponsor | Novartis, Industry |
| Collaborators | Novartis Vaccines Industry Chiron s.r.l. Beijing Representative Office |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Influenza vaccine |
| Enrollment | 600 |
| Start date | Jan 1, 2006 |
| First posted | Apr 4, 2006 |
| Last update posted | Sep 14, 2006 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: